Recent literature has addressed intracortical inhibition (ICI) and facilitation (ICF) and the impact of dopaminergic therapy in Parkinson's disease (PD)
Recent literature has addressed intracortical inhibition (ICI) and facilitation (ICF) and the impact of dopaminergic therapy in Parkinson's disease (PD) (en)